Genentech Receives Blow by FDA in Cancer Drug Avastin Biosimilar Battle, an Industrial Info News Alert
SUGAR LAND, Texas, Sept. 18, 2017 /PRNewswire/ -- Researched by Annette Kreuger, Industrial Info Resources --Biological drug maker Genentech, the developer of the blockbuster cancer drug Avastin, was dealt a stunning blow on September 14 when the U.S. Food and Drug Administration approved a biosimilar (generic biological drug). The biosimilar, Mvasi (bevacizumab-awwb), the result of a partnership between Amgen and Allergan, was approved for certain colorectal, lung, brain, kidney and cervical cancers.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principletm, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.
BDV Solutions, the leading provider of untapped global talent to support the needs of hiring organizations across the U.S. economy, today announced it has acquired Arkansas Global Connect (AGC), a Conway, Arkansas-based company that provides U.S....
The B.C. Securities Commission (BCSC) issued a BC Notice today to raise awareness of a 2023 Commission decision about promotional disclosure, and how it must be presented to comply with the law.
The decision, Re Stock Social Inc., interpreted a...
Aurum Lake Mining Corporation ("Aurum" or the "Company") ? is pleased to announce that it has completed its continuation from British Columbia under the Business Corporations Act (British Columbia) ("BCBCA") into the jurisdiction of the Cayman...
AltC Acquisition Corp. ("AltC") , a special purpose acquisition company, and Oklo Inc. ("Oklo"), a fast fission clean power technology and nuclear fuel recycling company, today announced that a special meeting of AltC stockholders (the "Special...
April 25, 2024 ? Evolve Funds Group Inc. ("Evolve") announces the following changes to the risk rating of the Evolve NASDAQ Technology Index Fund ("Evolve Fund"), as indicated in the table below. The following changes to the risk rating of the Evolve...
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...
